CNS Pharmaceuticals (CNSP) Reports Q4 Loss of $0.17/sh
Tweet
Share
E-mailGet Alerts CNSP Hot Sheet
Join SI Premium – FREE
CNS Pharmaceuticals (NASDAQ: CNSP) reported Q4 EPS of ($0.17), versus ($0.63) reported last year.
For earnings history and earnings-related data on CNS Pharmaceuticals (CNSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Materialise NV (MTLS) Reports Q2 EPS of EUR0.06
- HP Inc. (HPQ) Tops Q3 EPS by 17c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
